Lara Hashimoto

SVP & Chief Business Officer at SOPHiA GENETICS

Growing up in Canada, Lara developed an early interest in understanding the role of genetics in common diseases. This took her from studying genetics of Multiple Sclerosis at the University of Western Ontario to joining the Wellcome Trust Centre for Human Genetics at the University of Oxford, UK. Lara joined SOPHiA GENETICS in 2020, but first joined industry 20 years ago as a Scientist at Roche Pharma based in Basel, Switzerland. She has held several positions spanning Pharma clinical drug development, business analytics and strategic marketing in the global organization as well as sales and operational marketing positions in the Canadian affiliate. In 2009, Lara moved to Roche Molecular Diagnostics in California as the Lifecycle Leader responsible for the Genomics and Oncology IVD product portfolio and pipeline, launching several companion diagnostics globally. Lara then became the General Manager of Roche Diagnostics New Zealand Ltd where she grew sales above market for 4 consecutive years. Returning to the Bay Area, Lara then joined the newly formed Roche Sequencing Solutions team where she was the VP responsible for Non-Invasive Prenatal Testing and the Nanopore Sequencer before being appointed Chief Commercial Officer.

Roles

  • SVP & Chief Business Officer

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.